These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22686037)

  • 1. [Usefulness of serum procalcitonin measurement in the diagnosis of bacterial infection in patients with systemic autoimmune diseases].
    Takajo I; Yamamoto I; Umeki K; Okayama A
    Rinsho Byori; 2012 Apr; 60(4):294-9. PubMed ID: 22686037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases.
    Tamaki K; Kogata Y; Sugiyama D; Nakazawa T; Hatachi S; Kageyama G; Nishimura K; Morinobu A; Kumagai S
    J Rheumatol; 2008 Jan; 35(1):114-9. PubMed ID: 18050369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
    Sitter T; Schmidt M; Schneider S; Schiffl H
    J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases.
    Scirè CA; Cavagna L; Perotti C; Bruschi E; Caporali R; Montecucco C
    Clin Exp Rheumatol; 2006; 24(2):123-8. PubMed ID: 16762145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum procalcitonin in systemic autoimmune diseases--where are we now?
    Buhaescu I; Yood RA; Izzedine H
    Semin Arthritis Rheum; 2010 Oct; 40(2):176-83. PubMed ID: 20132965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assay for determination of the serum procalcitonin level: biochemical and clinical evaluation].
    Shimetani N; Ohba Y; Shimetani K; Mashiko T; Matsuyama N; Ohtani H; Morii M
    Rinsho Byori; 2001 Jan; 49(1):56-60. PubMed ID: 11215485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection.
    Eberhard OK; Haubitz M; Brunkhorst FM; Kliem V; Koch KM; Brunkhorst R
    Arthritis Rheum; 1997 Jul; 40(7):1250-6. PubMed ID: 9214425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum procalcitonin for differentiating bacterial infection from disease flares in patients with autoimmune diseases.
    Joo K; Park W; Lim MJ; Kwon SR; Yoon J
    J Korean Med Sci; 2011 Sep; 26(9):1147-51. PubMed ID: 21935268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus.
    Lanoix JP; Bourgeois AM; Schmidt J; Desblache J; Salle V; Smail A; Mazière JC; Betsou F; Choukroun G; Duhaut P; Ducroix JP
    Lupus; 2011 Feb; 20(2):125-30. PubMed ID: 20937623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus.
    Yu J; Xu B; Huang Y; Zhao J; Wang S; Wang H; Yang N
    Mod Rheumatol; 2014 May; 24(3):457-63. PubMed ID: 24252006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis of bacterial infection using procalcitonin].
    Takajo I; Okayama A
    Rinsho Byori; 2010 May; 58(5):517-22. PubMed ID: 20560461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.
    Lin CH; Hsieh SC; Keng LT; Lee HS; Chang HT; Liao WY; Ho CC; Yu CJ
    PLoS One; 2016; 11(4):e0153938. PubMed ID: 27096761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection.
    Brunkhorst R; Eberhardt OK; Haubitz M; Brunkhorst FM
    Intensive Care Med; 2000 Mar; 26 Suppl 2():S199-201. PubMed ID: 18470720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin is a specific marker for detecting bacterial infection in patients with rheumatoid arthritis.
    Sato H; Tanabe N; Murasawa A; Otaki Y; Sakai T; Sugaya T; Ito S; Otani H; Abe A; Ishikawa H; Nakazono K; Kuroda T; Nakano M; Narita I
    J Rheumatol; 2012 Aug; 39(8):1517-23. PubMed ID: 22753652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum procalcitonin levels in patients with myeloperoxidase-antineutrophil cytoplasmic antibodies-associated glomerulonephritis.
    Komatsuda A; Omokawa A; Fujiwara T; Sato R; Togashi M; Okuyama S; Sawada KI; Wakui H
    Am J Med Sci; 2012 Feb; 343(2):136-140. PubMed ID: 21817883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum procalcitonin has negative predictive value for bacterial infection in active systemic lupus erythematosus.
    Bador KM; Intan S; Hussin S; Gafor AH
    Lupus; 2012 Oct; 21(11):1172-7. PubMed ID: 22652631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of the measurement of serum procalcitonin: comparative study of procalcitonin and serum amyloid A protein in patients with high and low concentrations of serum C-reactive protein.
    Shimetani N; Shimetani K; Mori M
    Scand J Clin Lab Invest; 2004; 64(5):469-74. PubMed ID: 15276911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRP levels in autoimmune disease can be specified by measurement of procalcitonin.
    Schwenger V; Sis J; Breitbart A; Andrassy K
    Infection; 1998; 26(5):274-6. PubMed ID: 9795783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of serum procalcitonin measurement in the diagnosis of respiratory infectious diseases].
    Kurata K; Kazuyori T; Shimizu K; Kubota M; Hamaguchi R; Wakaki M; Goto T; Onaka A; Kato R; Oyamada Y
    Nihon Kokyuki Gakkai Zasshi; 2010 Sep; 48(9):654-60. PubMed ID: 20954366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations on the usefulness of procalcitonin as a marker of infection in patients with systemic autoimmune disease: comment on the article by Eberhard et al.
    Moosig F; Reinhold-Keller E; Csernok E; Gross WL
    Arthritis Rheum; 1998 Mar; 41(3):566-7; author reply 568. PubMed ID: 9506590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.